The European Union's pharmaceutical sector is in a perpetual state of progression. With rigorous regulations, growing patient demands, and the accelerated pace of development, navigating this complex landscape requires a tactical approach. Pharmaceutical companies must evolve to these changes by adopting advanced technologies, collaborating with ke